TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/23 18:54 | 9/15/23 | ADVM | Adverum Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Seyedkazemi Setareh | CA | O | Chief De | S | -9 | 1.52 | 0 | -6 | -12 | 48 | D | ||||||||||||||
9/21/22 20:00 | 9/19/22 | ADVM | Adverum Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Seyedkazemi Setareh | CA | O | Chief De | S | -6 | 1.07 | 0 | -6 | -11 | 48 | D | ||||||||||||||
5/24/22 16:47 | 5/23/22 | ADVM | Adverum Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Seyedkazemi Setareh | CA | O | Chief De | P | 17 | 0.8400 | 0 | 20 | 999% | 21 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |